IDXG
INTERPACE BIOSCIENCES NEW
stockOTC
advancing patient care through molecular diagnostic testing. interpace diagnostics develops molecular diagnostic tests. our molecular diagnostic tests provide unparalleled accuracy and clarity to improve outcomes in patients facing a cancer diagnosis. you can be assured that all of the molecular tests we offer are driven by rigorous, validated science. we power the future of molecular diagnostics, delivering cutting-edge and much-needed mutational analysis that helps risk-stratify for thyroid, pancreatic, and other cancers to better inform treatment decisions. the unique molecular diagnostic tests we offer enable healthcare providers to avoid unnecessary surgeries and better assess the risk of cancer progression in their patients.
| Period | Price | Date | Change | Beta |
|---|---|---|---|---|
| 1W | 6.42 | 2026-09-28 | -6.15% | -9.345 |
| 1M | 7.25 | 2026-08-26 | -16.90% | 0.205 |
| 3M | 1.65 | 2026-07-06 | +265.15% | -22.536 |
| 6M | 1.97 | 2026-04-06 | +205.84% | -5.031 |
| 1Y | 0.84 | 2025-10-06 | +617.26% | -1.693 |
| 2Y | 2.01 | 2024-10-04 | +200.50% | — |
| 5Y | 8.75 | 2021-10-05 | -31.14% | -0.140 |
INTERPACE BIOSCIENCES NEW (OTC:IDXG) stock price today is $6.03, and today's volume is 765. IDXG is down 5.712% today. The 30 day average volume is 5,823. IDXG market cap is $26.35M with 4.37M shares outstanding.